Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2457

1.

Microangiopathy is associated with bone loss in female type 2 diabetes mellitus patients.

Zhong N, Zhang Y, Pu X, Xu B, Xu M, Cai H, Zhang G, Cui R, Sheng H, Qu S.

Diab Vasc Dis Res. 2018 Jun 1:1479164118779386. doi: 10.1177/1479164118779386. [Epub ahead of print]

PMID:
29893142
2.

Leptin, cardiovascular diseases and type 2 diabetes mellitus.

Katsiki N, Mikhailidis DP, Banach M.

Acta Pharmacol Sin. 2018 Jun 7. doi: 10.1038/aps.2018.40. [Epub ahead of print] Review.

PMID:
29877321
3.

Combined Administration of Monosodium Glutamate and High Sucrose Diet Accelerates the Induction of Type 2 Diabetes, Vascular Dysfunction, and Memory Impairment in Rats.

Saikrishna K, Kumari R, Chaitanya K, Biswas S, Nayak PG, Mudgal J, Kishore A, Nandakumar K.

J Environ Pathol Toxicol Oncol. 2018;37(1):63-80. doi: 10.1615/JEnvironPatholToxicolOncol.2018017186.

PMID:
29773001
4.

Comparing the Economic Burden of Type 2 Diabetes Mellitus Patients with and without Medical Insurance: A Cross-Sectional Study in China.

Yang C, Huang Z, Sun K, Hu Y, Bao X.

Med Sci Monit. 2018 May 12;24:3098-3102. doi: 10.12659/MSM.907909.

5.

Comparative Cardiovascular Risks of Dipeptidyl Peptidase-4 Inhibitors: Analyses of Real-world Data in Korea.

Ha KH, Kim B, Shin HS, Lee J, Choi H, Kim HC, Kim DJ.

Korean Circ J. 2018 May;48(5):395-405. doi: 10.4070/kcj.2017.0324. Epub 2018 Feb 27.

6.

Glycemic control of type 2 diabetes mellitus across stages of renal impairment: information for primary care providers.

Tong L, Adler S.

Postgrad Med. 2018 May;130(4):381-393. doi: 10.1080/00325481.2018.1457397. Epub 2018 Apr 18. Review.

PMID:
29667921
7.

The Potential Role of SGLT2 Inhibitors in the Treatment of Type 1 Diabetes Mellitus.

Fattah H, Vallon V.

Drugs. 2018 May;78(7):717-726. doi: 10.1007/s40265-018-0901-y.

PMID:
29663292
8.

Changes in Trace Elements During Early Stages of Chronic Kidney Disease in Type 2 Diabetic Patients.

Lin CC, Shih CT, Lee CH, Huang YL.

Biol Trace Elem Res. 2018 Mar 28. doi: 10.1007/s12011-018-1314-1. [Epub ahead of print]

PMID:
29589268
9.

An Exploratory Study of Dapagliflozin for the Attenuation of Albuminuria in Patients with Heart Failure and Type 2 Diabetes Mellitus (DAPPER).

Yoshihara F, Imazu M, Hamasaki T, Anzai T, Yasuda S, Ito S, Yamamoto H, Hashimura K, Yasumura Y, Mori K, Watanabe M, Asakura M, Kitakaze M; DAPPER investigators and study coordinators.

Cardiovasc Drugs Ther. 2018 Apr;32(2):183-190. doi: 10.1007/s10557-018-6782-1.

PMID:
29589153
10.

The associations of metabolic syndrome with incident hypertension, type 2 diabetes mellitus and chronic kidney disease: a cohort study.

Ding C, Yang Z, Wang S, Sun F, Zhan S.

Endocrine. 2018 May;60(2):282-291. doi: 10.1007/s12020-018-1552-1. Epub 2018 Feb 28.

PMID:
29492904
11.

A Prospective Cohort Study in Patients with Type 2 Diabetes Mellitus for Validation of Biomarkers (PROVALID) - Study Design and Baseline Characteristics.

Eder S, Leierer J, Kerschbaum J, Rosivall L, Wiecek A, de Zeeuw D, Mark PB, Heinze G, Rossing P, Heerspink HL, Mayer G.

Kidney Blood Press Res. 2018;43(1):181-190. doi: 10.1159/000487500. Epub 2018 Feb 16.

12.

Gut microbiota and probiotics intervention: A potential therapeutic target for management of cardiometabolic disorders and chronic kidney disease?

Cavalcanti Neto MP, Aquino JS, Romão da Silva LF, de Oliveira Silva R, Guimarães KSL, de Oliveira Y, de Souza EL, Magnani M, Vidal H, de Brito Alves JL.

Pharmacol Res. 2018 Apr;130:152-163. doi: 10.1016/j.phrs.2018.01.020. Epub 2018 Feb 14. Review.

PMID:
29410236
13.

Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes.

Garlo KG, White WB, Bakris GL, Zannad F, Wilson CA, Kupfer S, Vaduganathan M, Morrow DA, Cannon CP, Charytan DM.

Clin J Am Soc Nephrol. 2018 Mar 7;13(3):398-405. doi: 10.2215/CJN.05280517. Epub 2018 Jan 16.

PMID:
29339356
14.

[The clinicopathological characteristics of diabetic nephropathy and non-diabetic renal diseases in diabetic patients].

Xu J, Hu XF, Huang W, Shen PY, Zhang W, Ren H, Li X, Wang WM, Chen N, Pan XX.

Zhonghua Nei Ke Za Zhi. 2017 Dec 1;56(12):924-929. doi: 10.3760/cma.j.issn.0578-1426.2017.12.007. Chinese.

PMID:
29202533
15.

Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases.

Han E, Lee YH.

Diabetes Metab J. 2017 Dec;41(6):430-437. doi: 10.4093/dmj.2017.41.6.430. Epub 2017 Nov 17. Review.

16.

Inadequate Glycaemic Control and Therapeutic Management of Adults over 65 Years Old with Type 2 Diabetes Mellitus in Spain.

Formiga F, Franch-Nadal J, Rodriguez L, Ávila L, Fuster E.

J Nutr Health Aging. 2017;21(10):1365-1370. doi: 10.1007/s12603-017-0869-4.

PMID:
29188902
17.

Association of smoking with prevalence of common diseases and metabolic abnormalities in community-dwelling Japanese individuals.

Ueyama C, Horibe H, Yamase Y, Fujimaki T, Oguri M, Kato K, Yamada Y.

Biomed Rep. 2017 Nov;7(5):429-438. doi: 10.3892/br.2017.991. Epub 2017 Sep 27.

18.

Cost-effectiveness of screening type 2 diabetes patients for chronic kidney disease progression with the CKD273 urinary peptide classifier as compared to urinary albumin excretion.

Critselis E, Vlahou A, Stel VS, Morton RL.

Nephrol Dial Transplant. 2018 Mar 1;33(3):441-449. doi: 10.1093/ndt/gfx068.

PMID:
29106632
19.

The effect of renal denervation in an experimental model of chronic renal insufficiency, The REmnant kidney Denervation In Pigs study (REDIP study).

Lubanda JC, Chochola M, Mlček M, Neužil P, Marek J, Havránek Š, Kuchynková S, Fingrová Z, Huang KA, Linhart A.

J Transl Med. 2017 Oct 25;15(1):215. doi: 10.1186/s12967-017-1319-0.

20.

ANCA and IgA glomerulonephritis all in one: prognosis and complications.

Nissaisorakarn P, D'Agati V, Anis K, Jim B.

BMJ Case Rep. 2017 Oct 9;2017. pii: bcr-2017-222080. doi: 10.1136/bcr-2017-222080.

PMID:
29018146

Supplemental Content

Loading ...
Support Center